NNC0519-0130
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Novo Nordisk · Phase 2 · Recruiting · Enrollment 465
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.